UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

Journal of clinical oncology, 2003-03, Vol.21 (6), p.976-983

2003

Volltextzugriff (PDF)

A Concise History of the Cancer and Leukemia Group B

Clinical cancer research, 2006-06, Vol.12 (11), p.3553s-3555s

2006

Volltextzugriff (PDF)

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

The New England journal of medicine, 1990-10, Vol.323 (14), p.940-945

1990

Volltextzugriff (PDF)

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

Science (American Association for the Advancement of Science), 1990-03, Vol.247 (4949), p.1457-1461

1990

Volltextzugriff (PDF)

Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1175-1184

1999

Volltextzugriff (PDF)

Non-small Cell Lung Cancer

Chest, 1997-10, Vol.112 (4), p.266S-268S

Frei, Emil

1997

Volltextzugriff (PDF)

Safety and Efficacy of Using a Single Agent or a Phase II Agent Before Instituting Standard Combination Chemotherapy in Previously Untreated Metastatic Breast Cancer Patients: Report of a Randomized Study—Cancer and Leukemia Group B 8642

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1397-1406

1999

Volltextzugriff (PDF)

Curative cancer chemotherapy

Cancer research (Chicago, Ill.), 1985-12, Vol.45 (12), p.6523-6537

FREI, E. III

1985

Volltextzugriff (PDF)

Preclinical studies and clinical correlation of the effect of alkylating dose

Cancer research (Chicago, Ill.), 1988-11, Vol.48 (22), p.6417-6423

1988

Volltextzugriff (PDF)

Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II)

Cancer research (Chicago, Ill.), 1987-01, Vol.47 (2), p.388-393

1987

Volltextzugriff (PDF)

BJ Kennedy, M.D

The oncologist (Dayton, Ohio), 2003-08, Vol.8 (4), p.302-302

Frei, Emil

2003

Volltextzugriff (PDF)

Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long-term follow-up in 41 patients

Journal of surgical oncology, 1989-04, Vol.40 (4), p.266-274

1989

Volltextzugriff (PDF)

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

JNCI : Journal of the National Cancer Institute, 1998-08, Vol.90 (16), p.1205-1211

1998

Volltextzugriff (PDF)

Clinical cancer research: An embattled species

Cancer, 1982-11, Vol.50 (10), p.1979-1992

Frei, Emil

1982

Volltextzugriff (PDF)

Agricultural Machinery Paint With Automotive Finish Qualities

IST International Surface Technology, 2024-05, Vol.17 (2), p.40-41

Emil Frei GmbH & Co. KG

2024

Volltextzugriff (PDF)

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

The New England journal of medicine, 1994-10, Vol.331 (14), p.896-903

1994

Volltextzugriff (PDF)

Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1993-04, Vol.85 (7), p.559-566

1993

Volltextzugriff (PDF)

Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines

Cancer research (Chicago, Ill.), 1986-09, Vol.46 (9), p.4379-4383

1986

Volltextzugriff (PDF)

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia

Cancer research (Chicago, Ill.), 1983-11, Vol.43 (11), p.5601-5607

1983

Volltextzugriff (PDF)

Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856

Cancer investigation, 2001, Vol.19 (5), p.447-458

2001

Volltextzugriff (PDF)

Zero-Emission Coating Process for Steel Furniture

IST International Surface Technology, 2021-03, Vol.14 (1), p.30-31

Emil Frei GmbH & Co. KG

2021

Volltextzugriff (PDF)

Analysis of 4-Hydroxycyclophosphamide in Human Blood

Analytical biochemistry, 1995, Vol.224 (1), p.154-158

1995

Volltextzugriff (PDF)

Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo

Cancer research (Chicago, Ill.), 1989-11, Vol.49 (21), p.5994

1989

Volltextzugriff (PDF)

Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

The New England journal of medicine, 1994-05, Vol.330 (18), p.1253-1259

1994

Volltextzugriff (PDF)

1 – 25 von 359

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(291)
Mit Volltextzugriff
(243)

Publikationsform

Sprache

Englisch
(332)
Deutsch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(215)
Humans
(208)
Life Sciences & Biomedicine
(206)
Oncology
(113)
Female
(91)
Male
(81)
Adult
(76)
Biological And Medical Sciences
(71)
Medical Sciences
(70)
Middle Aged
(66)
Antineoplastic Agents
(62)
Pharmacology. Drug Treatments
(56)
General & Internal Medicine
(47)
Medicine, General & Internal
(46)
Animals
(44)
Chemotherapy
(43)
Aged
(39)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(37)
Drug Therapy, Combination
(36)
Mice
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

A Concise History of the Cancer and Leukemia Group B

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

Mobilization of Peripheral Blood Progenitor Cells by Chemotherapy and Granulocyte-Macrophage Colony-Stimulating Factor for Hematologic Support After High-Dose Intensification for Breast Cancer

Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome

Non-small Cell Lung Cancer

Safety and Efficacy of Using a Single Agent or a Phase II Agent Before Instituting Standard Combination Chemotherapy in Previously Untreated Metastatic Breast Cancer Patients: Report of a Randomized Study—Cancer and Leukemia Group B 8642

Curative cancer chemotherapy

Preclinical studies and clinical correlation of the effect of alkylating dose

Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II)

BJ Kennedy, M.D

Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long-term follow-up in 41 patients

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

Clinical cancer research: An embattled species

Agricultural Machinery Paint With Automotive Finish Qualities

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer

Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia

Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856

Zero-Emission Coating Process for Steel Furniture

Analysis of 4-Hydroxycyclophosphamide in Human Blood

Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo

Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

Suchergebnisse filtern